Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.59 |
| ▸ | CA3 | P07451 | 2/20 | 0.58 |
| ▸ | CA5A | P35218 | 2/20 | 0.58 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA4 | P22748 | 1/20 | 0.58 |
| ▸ | CA6 | P23280 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6819670 | 0.98 | ALDH1A1 (0.69) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL9430552 | 0.84 | ALDH1A1 (0.58) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL29982917 | 0.84 | MEN1 (1.00) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL9557113 | 0.83 | MEN1 (0.73) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL27889238 | 0.82 | ALDH1A1 (1.00) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL7608354 | 0.81 | MEN1 (0.70) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL316649 | 0.79 | MEN1 (0.79) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL11326199 | 0.78 | EPHX1 (0.52) | ALDH1A1EPHX1MAPTABCC4LMNA | |
| SCHEMBL570465 | 0.78 | CA3 (0.91) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL3221326 | 0.76 | MEN1 (0.83) | MEN1KMT2AALDH1A1SMN1; SMN2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8680062-B2 | System for delivering therapeutic agents into living cells and cells nuclei | Deliversir Ltd. (IL) | 2014-03-25 | — | — | US | disclosed |
| US-8093177-B2 | Metal oxides having molecular and/or biomolecular functionalization | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-01-10 | — | — | US | disclosed |
| US-20100108490-A1 | MOLECULAR AND BIOMOLECULAR FUNCTIONALIZATION OF METAL OXIDES | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2010-05-06 | — | — | US | disclosed |
| US-20080004234-A1 | System for delivering therapeutic agents into living cells and cells nuclei | SEGEV LABORATORIES LIMITED (IL) | 2008-01-03 | — | — | US | disclosed |
| US-20060160763-A1 | System for delivering therapeutic agents into living cells and cells nuclei | SEGEV LABORATORIES LIMITED (IL) | 2006-07-20 | — | — | US | disclosed |
| EP-0267996-A1 | New nucleotide derivatives | TAMIR BIOTECHNOLOGY LTD. (IL) | 1988-05-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160763-A1 | System for delivering therapeutic agents into living cells and cells nuclei | RCC1, NUMA1, ACIN1 | MEN1 1982/4885KMT2A 4420/4885ALDH1A1 3923/4885 |
| US-20080004234-A1 | System for delivering therapeutic agents into living cells and cells nuclei | RCC1, NUMA1, ACIN1 | MEN1 1982/4885KMT2A 4420/4885ALDH1A1 3923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.